← Open Payments lookup

JEAN PELLEGALLE: Open Payments

NPI 1013528884 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,329 in 120 payments from 11 companies in 2025. Trend: 2023 $33 · 2024 $1,497 · 2025 $2,329

Food & beverage: $2,329
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.29$679
Vanda Pharmaceuticals Inc.22$505
Teva Pharmaceuticals USA, Inc.14$315
ABBVIE INC.16$227
Alkermes, Inc.13$139
Lundbeck LLC10$136
Luye Pharma (USA) Ltd.5$109
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$102
Otsuka America Pharmaceutical, Inc.4$86
Janssen Pharmaceuticals, Inc1$18

Products named: INGREZZA, FANAPT, VRAYLAR, REXULTI, AUSTEDO XR, ARISTADA, UZEDY, ERZOFRI EXTENDED-RELEASE.

Industry payments across TX — which companies pay providers there.